SEC Form 4 · accession 0001437749-16-034860
CESCA THERAPEUTICS INC. · KOOL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Bagnall
Director
Period of report
Jul 1, 2016
Accepted (ET)
Jul 5, 2016 · 5:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811212
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock optionsF1 | $2.86 | Jul 1, 2016 | A | 1,250 | A | — | Jul 1, 2023 | Common Stock | 1,250 | 1,250 | D |
Explanation of responses
- F1Options vest monthly over a one year period.